{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:57:14Z","timestamp":1790704634778,"version":"4.1.0"},"reference-count":105,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Basic to Translational Science"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jacbts.2022.02.003","type":"journal-article","created":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T14:11:58Z","timestamp":1654697518000},"page":"956-969","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Utilization and Potential of RNA-Based Therapies in Cardiovascular Disease"],"prefix":"10.1016","volume":"7","author":[{"given":"Emma Louise","family":"Robinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. David","family":"Port","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacbts.2022.02.003_bib2","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","article-title":"2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA Guideline for the Management of Heart\u00a0Failure","volume":"70","author":"Yancy Clyde","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2022.02.003_bib3","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jacc.2016.07.739","article-title":"Preclinical development of a microRNA-based therapy for elderly patients with myocardial infarction","volume":"68","author":"Gupta","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2022.02.003_bib4","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.tips.2020.08.004","article-title":"Paving the road for RNA therapeutics","volume":"41","author":"Dammes","year":"2020","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jacbts.2022.02.003_bib5","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41565-021-00898-0","article-title":"The current landscape of nucleic acid therapeutics","volume":"16","author":"Kulkarni","year":"2021","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.jacbts.2022.02.003_bib6","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/CIRCRESAHA.119.315856","article-title":"Preclinical and clinical development of noncoding rna therapeutics for cardiovascular disease","volume":"126","author":"Huang","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2022.02.003_bib7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13073-017-0450-0","article-title":"Advances in the delivery of RNA therapeutics: from concept to clinical reality","volume":"9","author":"Kaczmarek","year":"2017","journal-title":"Genome Med"},{"key":"10.1016\/j.jacbts.2022.02.003_bib8","doi-asserted-by":"crossref","first-page":"628137","DOI":"10.3389\/fbioe.2021.628137","article-title":"The limitless future of RNA therapeutics","volume":"9","author":"Damase","year":"2021","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.jacbts.2022.02.003_bib9","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1093\/eurheartj\/ehaa229","article-title":"From traditional pharmacological towards nucleic acid-based therapies for cardiovascular diseases","volume":"41","author":"Landmesser","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2022.02.003_bib10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/MNH.0000000000000586","article-title":"Targeting angiotensinogen with RNA-based therapeutics","volume":"29","author":"Ren","year":"2020","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.jacbts.2022.02.003_bib11","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/cvr\/cvaa071","article-title":"Non-coding RNA therapeutics for cardiac regeneration","volume":"117","author":"Braga","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2022.02.003_bib12","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.bcp.2018.07.037","article-title":"RNA therapeutics for heart disease","volume":"155","author":"De Majo","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jacbts.2022.02.003_bib13","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","article-title":"Noncoding RNA therapeutics - challenges and potential solutions","volume":"20","author":"Winkle","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jacbts.2022.02.003_bib14","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in oligonucleotide drug delivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jacbts.2022.02.003_bib15","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3389\/fphys.2018.00953","article-title":"RNA therapeutics in cardiovascular precision medicine","volume":"9","author":"Laina","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.jacbts.2022.02.003_bib16","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cmet.2018.03.004","article-title":"RNA-targeted therapeutics","volume":"27","author":"Crooke","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.jacbts.2022.02.003_bib17","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/jcb.29364","article-title":"RNA therapeutics: Identification of novel targets leading to drug discovery","volume":"121","author":"Qadir","year":"2020","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.jacbts.2022.02.003_bib18","first-page":"138","article-title":"On protein synthesis","volume":"12","author":"Crick","year":"1958","journal-title":"Symp Soc Exp Biol"},{"key":"10.1016\/j.jacbts.2022.02.003_bib19","first-page":"366","article-title":"So much \u201cjunk\u201d DNA in our genome","volume":"23","author":"Ohno","year":"1972","journal-title":"Brookhaven Symp Biol"},{"key":"10.1016\/j.jacbts.2022.02.003_bib20","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.cell.2015.01.009","article-title":"A\u00a0micropeptide encoded by a putative long noncoding RNA regulates muscle performance","volume":"160","author":"Anderson","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jacbts.2022.02.003_bib21","doi-asserted-by":"crossref","first-page":"ra119","DOI":"10.1126\/scisignal.aaj1460","article-title":"Widespread control of calcium signaling by a family of SERCA-inhibiting micropeptides","volume":"9","author":"Anderson","year":"2016","journal-title":"Sci Signal"},{"key":"10.1016\/j.jacbts.2022.02.003_bib22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1126\/science.aad4076","article-title":"A\u00a0peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle","volume":"351","author":"Nelson","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jacbts.2022.02.003_bib23","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/CIRCRESAHA.110.223172","article-title":"Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction","volume":"107","author":"Small","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2022.02.003_bib24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12943-020-1147-3","article-title":"Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA","volume":"19","author":"Wu","year":"2020","journal-title":"Mol Cancer"},{"issue":"6","key":"10.1016\/j.jacbts.2022.02.003_bib25","doi-asserted-by":"crossref","first-page":"e00528","DOI":"10.1128\/MCB.00528-19","article-title":"When long noncoding becomes protein coding","volume":"40","author":"Hartford","year":"2020","journal-title":"Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.jacbts.2022.02.003_bib26","first-page":"3","article-title":"The missing \u201clnc\u201d between genetics and cardiac disease","volume":"6","author":"Azodi","year":"2020","journal-title":"Noncoding RNA"},{"key":"10.1016\/j.jacbts.2022.02.003_bib27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s12967-019-2071-4","article-title":"RNA editing in the forefront of epitranscriptomics and human health","volume":"17","author":"Christofi","year":"2019","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.jacbts.2022.02.003_bib28","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/cvr\/cvs013","article-title":"MicroRNAs in control of cardiac hypertrophy","volume":"93","author":"Da Costa Martins","year":"2012","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2022.02.003_bib29","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3389\/fgene.2019.00778","article-title":"Purification and identification of miRNA target sites in genome using DNA affinity precipitation","volume":"10","author":"Xun","year":"2019","journal-title":"Front Genet"},{"key":"10.1016\/j.jacbts.2022.02.003_bib30","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1101\/gad.1738708","article-title":"microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart","volume":"22","author":"Liu","year":"2008","journal-title":"Genes Dev"},{"key":"10.1016\/j.jacbts.2022.02.003_bib31","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1126\/science.1174381","article-title":"MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice","volume":"324","author":"Bonauer","year":"2009","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.jacbts.2022.02.003_bib32","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/nar\/gkab1256","article-title":"Reexamining assumptions about miRNA-guided gene silencing","volume":"50","author":"Kilikevicius","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jacbts.2022.02.003_bib33","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature09033","article-title":"Widespread transcription at neuronal activity-regulated enhancers","volume":"465","author":"Kim","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jacbts.2022.02.003_bib34","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41576-018-0017-y","article-title":"Towards a complete map of the human long non-coding RNA transcriptome","volume":"19","author":"Uszczynska-Ratajczak","year":"2018","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jacbts.2022.02.003_bib35","doi-asserted-by":"crossref","first-page":"D983","DOI":"10.1093\/nar\/gks1099","article-title":"LncRNADisease: a database for long-non-coding RNA-associated diseases","volume":"41","author":"Chen","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jacbts.2022.02.003_bib36","doi-asserted-by":"crossref","first-page":"D168","DOI":"10.1093\/nar\/gku988","article-title":"lncRNAdb v2.0: expanding the reference database for functional long noncoding RNAs","volume":"43","author":"Quek","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jacbts.2022.02.003_bib37","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nbt.2890","article-title":"Detecting and characterizing circular RNAs","volume":"32","author":"Jeck","year":"2014","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jacbts.2022.02.003_bib38","doi-asserted-by":"crossref","first-page":"5176","DOI":"10.1111\/jcmm.13789","article-title":"Circular RNAs: methodological challenges and perspectives in cardiovascular diseases","volume":"22","author":"Carrara","year":"2018","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.jacbts.2022.02.003_bib39","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1523\/JNEUROSCI.1348-17.2017","article-title":"Circular RNA DLGAP4 ameliorates ischemic stroke outcomes by targeting miR-143 to regulate endothelial-mesenchymal transition associated with blood-brain barrier integrity","volume":"38","author":"Bai","year":"2018","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.jacbts.2022.02.003_bib40","first-page":"298","article-title":"A\u00a0landscape of circular RNA expression in the human heart","volume":"113","author":"Tan","year":"2017","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2022.02.003_bib41","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.jacc.2016.06.040","article-title":"Myocardial infarction-associated circular RNA predicting left ventricular dysfunction","volume":"68","author":"Vausort","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2022.02.003_bib42","doi-asserted-by":"crossref","first-page":"e1633","DOI":"10.1002\/wrna.1633","article-title":"Practical guide for circular RNA analysis: Steps, tips, and resources","volume":"12","author":"Tsitsipatis","year":"2021","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"10.1016\/j.jacbts.2022.02.003_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/tnsci-2017-0001","article-title":"SS-N1 makes the first FDA-approved drug for spinal muscular atrophy","volume":"8","author":"Ottesen","year":"2017","journal-title":"Transl Neurosci"},{"key":"10.1016\/j.jacbts.2022.02.003_bib44","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1101\/gad.1941310","article-title":"Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model","volume":"24","author":"Hua","year":"2010","journal-title":"Genes Dev"},{"key":"10.1016\/j.jacbts.2022.02.003_bib45","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/nm.3200","article-title":"MicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion","volume":"19","author":"Soh","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.jacbts.2022.02.003_bib46","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4161\/rna.8.2.15391","article-title":"Diverse roles of host RNA binding proteins in RNA virus replication","volume":"8","author":"Li","year":"2011","journal-title":"RNA Biol"},{"key":"10.1016\/j.jacbts.2022.02.003_bib47","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/514866","article-title":"Insights from model systems. Embryonic lethal abnormal visual RNA-binding protiens involved in growth, differentiation, and posttranscriptional gene expression","volume":"61","author":"Antic","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jacbts.2022.02.003_bib48","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.molcel.2011.06.007","article-title":"Integrative regulatory mapping indicates that the RNA-binding protein HuR couples Pre-mRNA processing and mRNA stability","volume":"43","author":"Mukherjee","year":"2011","journal-title":"Mol Cell"},{"key":"10.1016\/j.jacbts.2022.02.003_bib49","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.celrep.2016.06.084","article-title":"The cardiomyocyte RNA-binding proteome: links to intermediary metabolism and heart disease","volume":"16","author":"Liao","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.jacbts.2022.02.003_bib50","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.ymthe.2020.04.006","article-title":"Engineered circular RNA sponges act as miRNA inhibitors to attenuate pressure overload-induced cardiac hypertrophy","volume":"28","author":"Lavenniah","year":"2020","journal-title":"Mol Ther"},{"key":"10.1016\/j.jacbts.2022.02.003_bib51","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrd1955","article-title":"Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease","volume":"5","author":"Ng","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jacbts.2022.02.003_bib52","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.jacbts.2022.02.003_bib53","first-page":"523","article-title":"Naturally occurring nucleoside modifications suppress the immunostimulatory activity of RNA: implication for therapeutic RNA development","volume":"10","author":"Karik\u00f3","year":"2007","journal-title":"Curr Opin Drug Discov Devel"},{"key":"10.1016\/j.jacbts.2022.02.003_bib54","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ymthe.2019.03.009","article-title":"In\u00a0vitro-Transcribed mRNA therapeutics: out of the shadows and into the spotlight","volume":"27","author":"Karik\u00f3","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.jacbts.2022.02.003_bib55","doi-asserted-by":"crossref","first-page":"12768","DOI":"10.1093\/nar\/gku941","article-title":"Modifications to toxic CUG RNAs induce structural stability, rescue mis-splicing in a myotonic dystrophy cell model and reduce toxicity in a myotonic dystrophy zebrafish model","volume":"42","author":"deLorimier","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jacbts.2022.02.003_bib56","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ymeth.2011.01.008","article-title":"Assembly of multifunctional phi29 pRNA nanoparticles for specific delivery of siRNA and other therapeutics to targeted cells","volume":"54","author":"Shu","year":"2011","journal-title":"Methods"},{"key":"10.1016\/j.jacbts.2022.02.003_bib57","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.canlet.2020.11.004","article-title":"Targeted delivery of small noncoding RNA for glioblastoma","volume":"500","author":"Yoo","year":"2021","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jacbts.2022.02.003_bib58","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1021\/acsnano.6b05910","article-title":"Overcoming tamoxifen resistance of human breast cancer by targeted gene silencing using multifunctional pRNA nanoparticles","volume":"11","author":"Zhang","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.jacbts.2022.02.003_bib59","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ymthe.2019.02.012","article-title":"Delivering the messenger: advances in technologies for therapeutic mRNA delivery","volume":"27","author":"Kowalski","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.jacbts.2022.02.003_bib60","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1124\/pr.120.019554","article-title":"RNA Drugs and RNA targets for small molecules: principles, progress, and challenges","volume":"72","author":"Yu","year":"2020","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jacbts.2022.02.003_bib61","doi-asserted-by":"crossref","first-page":"9026","DOI":"10.1093\/nar\/gkab718","article-title":"Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotides","volume":"49","author":"Anderson Brooke","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jacbts.2022.02.003_bib62","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.tips.2020.08.002","article-title":"Inhaled RNA therapy: from promise to reality","volume":"41","author":"Chow","year":"2020","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jacbts.2022.02.003_bib63","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/s41598-018-20632-6","article-title":"Oral delivery of siRNA lipid nanoparticles: fate in the GI tract","volume":"8","author":"Ball","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacbts.2022.02.003_bib64","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejps.2019.03.027","article-title":"Oral delivery of non-viral nucleic acid-based therapeutics - do we have the guts for this?","volume":"133","author":"O'Driscoll","year":"2019","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.jacbts.2022.02.003_bib65","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jid.2018.11.007","article-title":"A\u00a0MicroRNA-29 Mimic (Remlarsen) represses extracellular matrix expression and fibroplasia in the skin","volume":"139","author":"Gallant-Behm","year":"2019","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jacbts.2022.02.003_bib66","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/CIRCULATIONAHA.108.824177","article-title":"Systematizing serendipity for cardiovascular drug discovery","volume":"120","author":"Schlueter","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2022.02.003_bib67","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41467-017-00319-8","article-title":"Single cardiomyocyte nuclear transcriptomes reveal a lincRNA-regulated de-differentiation and cell cycle stress-response in\u00a0vivo","volume":"8","author":"See","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacbts.2022.02.003_bib68","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-06639-7","article-title":"Cardiomyocyte gene programs encoding morphological and functional signatures in cardiac hypertrophy and failure","volume":"9","author":"Nomura","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacbts.2022.02.003_bib69","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/nbt.3715","article-title":"Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library","volume":"34","author":"Zhu","year":"2016","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jacbts.2022.02.003_bib70","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature11739","article-title":"Functional screening identifies miRNAs inducing cardiac regeneration","volume":"492","author":"Eulalio","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jacbts.2022.02.003_bib71","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1161\/CIRCRESAHA.116.309589","article-title":"Single-dose intracardiac injection of pro-regenerative MicroRNAs improves cardiac function after myocardial infarction","volume":"120","author":"Lesizza","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2022.02.003_bib72","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41586-019-1191-6","article-title":"MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs","volume":"569","author":"Gabisonia","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jacbts.2022.02.003_bib73","doi-asserted-by":"crossref","first-page":"6055","DOI":"10.1038\/s41598-019-41491-9","article-title":"Functional screening identifies microRNAs as multi-cellular regulators of heart failure","volume":"9","author":"Verjans","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacbts.2022.02.003_bib74","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1152\/physrev.00046.2017","article-title":"Myoediting: toward prevention of muscular dystrophy by therapeutic genome editing","volume":"98","author":"Zhang","year":"2018","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jacbts.2022.02.003_bib75","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.1254445","article-title":"Prevention of muscular dystrophy in mice by CRISPR\/Cas9-mediated editing of germline DNA","volume":"345","author":"Long","year":"2014","journal-title":"Science"},{"issue":"22","key":"10.1016\/j.jacbts.2022.02.003_bib76","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2004840117","article-title":"Toward the correction of muscular dystrophy by gene editing","volume":"118","author":"Olson","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacbts.2022.02.003_bib77","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.ymthe.2020.05.024","article-title":"Correction of three prominent mutations in mouse and human models of duchenne muscular dystrophy by single-cut genome editing","volume":"28","author":"Min","year":"2020","journal-title":"Mol Ther"},{"issue":"18","key":"10.1016\/j.jacbts.2022.02.003_bib78","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg4910","article-title":"Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing","volume":"7","author":"Chemello","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.jacbts.2022.02.003_bib79","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/eurheartj\/ehaa791","article-title":"CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure","volume":"42","author":"Batkai","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2022.02.003_bib80","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/ncomms2090","article-title":"The miRNA-212\/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy","volume":"3","author":"Ucar","year":"2012","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacbts.2022.02.003_bib81","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41467-020-14349-2","article-title":"Preclinical development of a miR-132 inhibitor for heart failure treatment","volume":"11","author":"Foinquinos","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacbts.2022.02.003_bib82","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/eurheartj\/ehaa898","article-title":"Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study","volume":"42","author":"Taubel","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2022.02.003_bib83","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1089\/nat.2020.0871","article-title":"Efficiency and target derepression of anti-miR-92a: results of a first in human study","volume":"30","author":"Abplanalp","year":"2020","journal-title":"Nucleic Acid Ther"},{"key":"10.1016\/j.jacbts.2022.02.003_bib84","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/cvr\/cvu162","article-title":"Inhibition of miR-92a improves re-endothelialization and prevents neointima formation following vascular injury","volume":"103","author":"Daniel","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2022.02.003_bib85","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1161\/CIRCULATIONAHA.113.001904","article-title":"Inhibition of microRNA-92a protects against ischemia\/reperfusion injury in a large-animal model","volume":"128","author":"Hinkel","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2022.02.003_bib86","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1161\/CIRCRESAHA.117.311311","article-title":"RNA therapeutics in cardiovascular disease","volume":"123","author":"Lucas","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2022.02.003_bib87","doi-asserted-by":"crossref","first-page":"15162","DOI":"10.1038\/ncomms15162","article-title":"Light-inducible antimiR-92a as a therapeutic strategy to promote skin repair in healing-impaired diabetic mice","volume":"8","author":"Lucas","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacbts.2022.02.003_bib88","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.118.034598","article-title":"Analysis of cell type-specific effects of microRNA-92a provides novel insights into target regulation and mechanism of action","volume":"138","author":"Rogg","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2022.02.003_bib89","article-title":"Single intracoronary injection of encapsulated antagomir-92a promotes angiogenesis and prevents adverse infarct remodeling","volume":"3","author":"Bellera","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacbts.2022.02.003_bib90","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aai9118","article-title":"The long noncoding RNA Wisper controls cardiac fibrosis and remodeling","volume":"9","author":"Micheletti","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jacbts.2022.02.003_bib91","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1161\/CIRCULATIONAHA.110.968792","article-title":"Sex\/gender differences in cardiovascular disease prevention: what a difference a decade makes","volume":"124","author":"Mosca","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2022.02.003_bib92","author":"Khumbhani"},{"key":"10.1016\/j.jacbts.2022.02.003_bib93","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCULATIONAHA.121.057812","article-title":"Empagliflozin, health status, and quality of life in patients with heart failure and preserved ejection fraction: the EMPEROR-Preserved trial","volume":"145","author":"Butler","year":"2022","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jacbts.2022.02.003_bib94","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/CIRCULATIONAHA.117.030742","article-title":"Single-cell sequencing of the healthy and diseased heart reveals cytoskeleton-associated protein 4 as a new modulator of fibroblasts activation","volume":"138","author":"Gladka","year":"2018","journal-title":"Circulation"},{"issue":"612","key":"10.1016\/j.jacbts.2022.02.003_bib95","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf2750","article-title":"Epicardial differentiation drives fibro-fatty remodeling in arrhythmogenic cardiomyopathy","volume":"13","author":"Kohela","year":"2021","journal-title":"Sci Transl Med"},{"issue":"7683","key":"10.1016\/j.jacbts.2022.02.003_bib96","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature24676","article-title":"IL-11 is a crucial determinant of cardiovascular fibrosis","volume":"552","author":"Schafer","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jacbts.2022.02.003_bib97","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12916-019-1469-4","article-title":"Multi-level transcriptome sequencing identifies COL1A1 as a candidate marker in human heart failure progression","volume":"18","author":"Hua","year":"2020","journal-title":"BMC Med"},{"issue":"21","key":"10.1016\/j.jacbts.2022.02.003_bib98","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1161\/CIRCULATIONAHA.115.021019","article-title":"Smooth muscle enriched long noncoding RNA (SMILR) regulates cell proliferation","volume":"133","author":"Ballantyne","year":"2016","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jacbts.2022.02.003_bib99","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/ATVBAHA.114.303240","article-title":"Identification and initial functional characterization of a human vascular cell-enriched long noncoding RNA","volume":"34","author":"Bell","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"19","key":"10.1016\/j.jacbts.2022.02.003_bib100","doi-asserted-by":"crossref","first-page":"15672","DOI":"10.1074\/jbc.M111.322669","article-title":"Small RNA sequencing reveals microRNAs that modulate angiotensin II effects in vascular smooth muscle cells","volume":"287","author":"Jin","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacbts.2022.02.003_bib101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2015.01.008","article-title":"Deciphering the microRNA signature of pathological cardiac hypertrophy by engineered heart tissue- and sequencing-technology","volume":"81","author":"Hirt","year":"2015","journal-title":"J\u00a0Mol Cell Cardiol"},{"issue":"19","key":"10.1016\/j.jacbts.2022.02.003_bib102","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/CIRCULATIONAHA.119.044557","article-title":"Single-cell RNA sequencing analysis reveals a crucial role for CTHRC1 (collagen triple helix repeat containing 1) cardiac fibroblasts after myocardial infarction","volume":"142","author":"Ruiz-Villalba","year":"2020","journal-title":"Circulation"},{"issue":"7867","key":"10.1016\/j.jacbts.2022.02.003_bib103","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/s41586-021-03674-1","article-title":"A\u00a0transcriptional switch governs fibroblast activation in heart disease","volume":"595","author":"Alexanian","year":"2021","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.jacbts.2022.02.003_bib104","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.2337\/db17-1434","article-title":"miRNA regulation of the hyperproliferative phenotype of vascular smooth muscle cells in diabetes","volume":"67","author":"Torella","year":"2018","journal-title":"Diabetes"},{"issue":"14","key":"10.1016\/j.jacbts.2022.02.003_bib105","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1093\/cvr\/cvz130","article-title":"Targeting the highly abundant circular RNA circSlc8a1 in cardiomyocytes attenuates pressure overload induced hypertrophy","volume":"115","author":"Lim","year":"2019","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2022.02.003_bib106","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3389\/fgene.2020.00212","article-title":"Circular RNA-expression profiling reveals a potential role of hsa_circ_0097435 in heart failure via sponging multiple microRNAs","volume":"11","author":"Han","year":"2020","journal-title":"Front Genet"}],"container-title":["JACC: Basic to Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X22000389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X22000389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:25:48Z","timestamp":1762820748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452302X22000389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":105,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S2452302X22000389"],"URL":"https:\/\/doi.org\/10.1016\/j.jacbts.2022.02.003","relation":{},"ISSN":["2452-302X"],"issn-type":[{"value":"2452-302X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utilization and Potential of RNA-Based Therapies in Cardiovascular Disease","name":"articletitle","label":"Article Title"},{"value":"JACC: Basic to Translational Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2022.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}